216 related articles for article (PubMed ID: 23406561)
1. Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?
Dalla Pria A; Hayward K; Bower M
Expert Rev Anticancer Ther; 2013 Feb; 13(2):203-9. PubMed ID: 23406561
[TBL] [Abstract][Full Text] [Related]
2. Facing up to the ongoing challenge of Kaposi's sarcoma.
Robey RC; Bower M
Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104
[TBL] [Abstract][Full Text] [Related]
3. Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.
Bower M; Dalla Pria A; Coyle C; Andrews E; Tittle V; Dhoot S; Nelson M
J Clin Oncol; 2014 Feb; 32(5):409-14. PubMed ID: 24378415
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
5. AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.
Chu KM; Mahlangeni G; Swannet S; Ford NP; Boulle A; Van Cutsem G
J Int AIDS Soc; 2010 Jul; 13():23. PubMed ID: 20615222
[TBL] [Abstract][Full Text] [Related]
6. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
10. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
12. Steroid-exacerbated HIV-associated cutaneous Kaposi's sarcoma immune reconstitution inflammatory syndrome: 'Where a good intention turns bad'.
Chabria S; Barakat L; Ogbuagu O
Int J STD AIDS; 2016 Oct; 27(11):1026-9. PubMed ID: 26769754
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa.
Mosam A; Uldrick TS; Shaik F; Carrara H; Aboobaker J; Coovadia H
Int J STD AIDS; 2011 Nov; 22(11):671-3. PubMed ID: 22096054
[TBL] [Abstract][Full Text] [Related]
14. Life-threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome.
Volkow PF; Cornejo P; Zinser JW; Ormsby CE; Reyes-Terán G
AIDS; 2008 Mar; 22(5):663-5. PubMed ID: 18317012
[No Abstract] [Full Text] [Related]
15. Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study.
Dalu D; Fasola C; Ammoni L; De Francesco D; Cona MS; Rota S; Ferrario S; Gambaro A; Tosca N; Piva S; La Verde N
J Chemother; 2021 Sep; 33(5):342-347. PubMed ID: 34060438
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849
[TBL] [Abstract][Full Text] [Related]
17. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: successful treatment with interferon-alpha.
Ueno T; Mitsuishi T; Kimura Y; Kato T; Hasegawa H; Katano H; Sata T; Kurane S; Kawana S
Eur J Dermatol; 2007; 17(6):539-40. PubMed ID: 17951139
[No Abstract] [Full Text] [Related]
18. HIV-Associated Kaposi's Sarcoma.
Hoffmann C; Sabranski M; Esser S
Oncol Res Treat; 2017; 40(3):94-98. PubMed ID: 28259888
[TBL] [Abstract][Full Text] [Related]
19. Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment.
Monticelli A; Lewi D; Salomon H; Pampuro S; Libonatti O; Jauregui Rueda H; Hodara V
Rev Argent Microbiol; 2000; 32(4):206-8. PubMed ID: 11149154
[TBL] [Abstract][Full Text] [Related]
20. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
